Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation

Kim, JW; Cardin, DB; Vaishampayan, UN; Kato, S; Grossman, SR; Glazer, PM; Shyr, Y; Ivy, SP; LoRusso, PM

Kim, JW (corresponding author), Yale Sch Med, Med Oncol, 333 Cedar St,FMP 121, New Haven, CT 06510 USA.

ONCOLOGIST, 2021; 26 (7): E1104

Abstract

Lessons Learned Cediranib and olaparib combination did not result in clinically meaningful activity in patients with metastatic pancreatic ductal aden......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索